Docetaxel Consolidation Therapy Following Cisplatin, Vinorelbine, and Concurrent Thoracic Radiotherapy in Patients with Unresectable Stage III Non-small Cell Lung Cancer
Docetaxel Consolidation Therapy Following Cisplatin, Vinorelbine, and Concurrent Thoracic...
Tamura, Tomohide
2006-10-01 00:00:00
This regimen produced promising overall survival in patients with stage III NSCLC, but the vast majority of patients could not continue with the docetaxel consolidation because of toxicity.
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngJournal of Thoracic OncologyWolters Kluwer Healthhttp://www.deepdyve.com/lp/wolters-kluwer-health/docetaxel-consolidation-therapy-following-cisplatin-vinorelbine-and-iTiOX9a5ye
Docetaxel Consolidation Therapy Following Cisplatin, Vinorelbine, and Concurrent Thoracic Radiotherapy in Patients with Unresectable Stage III Non-small Cell Lung Cancer
This regimen produced promising overall survival in patients with stage III NSCLC, but the vast majority of patients could not continue with the docetaxel consolidation because of toxicity.
Journal
Journal of Thoracic Oncology
– Wolters Kluwer Health
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.